Fy18 Nofo

Centers for Disease Control
National Center for Environmental Health
Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning
Prevention and Surveillance of Blood Lead Levels in Children
CDC-RFA-EH18-1806
Application Due Date: 08/09/2018

Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning
Prevention and Surveillance of Blood Lead Levels in Children
CDC-RFA-EH18-1806
TABLE OF CONTENTS
Part I. Overview Information
A. Federal Agency Name
B. Funding Opportunity Title
C. Announcement Type
D. Agency Funding Opportunity Number
E. Catalog of Federal Domestic Assistance (CFDA) Number
F. Dates
G. Executive Summary
Part II. Full Text
A. Funding Opportunity Description
B. Award Information
C. Eligibility Information
D. Application and Submission Information
E. Review and Selection Process
F. Award Administration Information
G. Agency Contacts
H. Other Information
I. Glossary

Part I. Overview Information
Applicants must go to the synopsis page of this announcement at www.grants.gov and click on
the "Send Me Change Notifications Emails" link to ensure they receive notifications of any
changes to CDC-RFA-EH18-1806. Applicants also must provide an e-mail address to
www.grants.gov to receive notifications of changes.
A. Federal Agency Name:
Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease
Registry (ATSDR)
B. Notice of Funding Opportunity (NOFO) Title:
Childhood Lead Poisoning Prevention Projects, State and Local Childhood Lead Poisoning
Prevention and Surveillance of Blood Lead Levels in Children
C. Announcement Type: New - Type 1
This announcement is only for non-research activities supported by CDC. If research is
proposed, the application will not be considered. For this purpose, research is defined at https
://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.
Guidance on how CDC interprets the definition of research in the context of public health can
be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html
(See section 45 CFR 46.102(d)).
http://www.cdc.gov/od/science/integrity/docs/cdc-policy-distinguishing-public-health-researchnonresearch.pdf
D. Agency Notice of Funding Opportunity Number:
CDC-RFA-EH18-1806
E. Catalog of Federal Domestic Assistance (CFDA) Number:
93.197
F. Dates:
1. Due Date for Letter of Intent (LOI):
N/A
2. Due Date for Applications:
08/09/2018, 11:59 p.m. U.S. Eastern
Standard Time, at www.grants.gov.
3. Date for Informational Conference Call:
An informational conference call will occur on Tuesday, July 17, 2018, from 2 to 3 p.m. eastern
standard time. Call-in information is 855-644-0229, conference ID 6530827
Updated details about the informational call will be posted at: https://www.cdc.gov/nceh/lead/
G. Executive Summary:
1. Summary Paragraph:
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year
(FY) 2018 funds that will be awarded through cooperative agreements to support childhood lead
poisoning prevention activities including: blood lead testing, surveillance, and targeted
population-based interventions. In addition, as part of this Notice of Funding Opportunity
(NOFO), recipients will be expected to demonstrate that processes are in place to identify leadexposed children and link them to recommended services. More specifically, recipients will be

1 of 48

expected to work closely with other agencies, partners, other stakeholders serving children to
ensure that a comprehensive system of referral, follow-up and evaluation is in place for leadexposed children.
a. Eligible Applicants:
b. NOFO Type:
c. Approximate Number of Awards:

Limited
Cooperative Agreement
10

d. Total Period of Performance Funding:

$10,000,000

e. Average One Year Award Amount:

$400,000

f. Total Period of Performance Length:
2
g. Estimated Award Date:
09/30/2018
h. Cost Sharing and / or Matching Requirements: N
No cost sharing or matching funds are required for this program. Although no statutory
matching requirement for this NOFO exists, leveraging other resources and related ongoing
efforts to promote sustainability is strongly encouraged.
Part II. Full Text
A. Funding Opportunity Description
Part II. Full Text
1. Background
a. Overview
An estimated 500,000 children in the United States have blood lead levels (BLLs) at or above
the CDC blood lead reference value. These children are at-risk for the intellectual and
behavioral deficits and other adverse health effects caused by exposure to lead. The primary
source of lead exposure to children is the home environment: some 38 million homes in the
United States have lead-based paint hazards that can result in childhood lead poisoning. Lowincome and minority children bear a disproportionate burden of lead exposure risk caused by
lead hazards in the home environment. In addition, some areas of the United States report that
as many as 35% of children identified with elevated BLLs are exposed to lead through sources
other than lead-based paint in their homes (e.g., such as items decorated or made with lead).
Public health action is needed to support activities to monitor and prevent lead exposure in
children, to address lead hazards, and to eliminate childhood lead poisoning as a public health
problem.
b. Statutory Authorities
This program is authorized under Sections 317(k)(2) and 317(A) of the Public Health Service
Act, (42 U.S.C. Sections 247b(k)(2) and 247b-3(b)), as amended.
c. Healthy People 2020
2 of 48

The National Center for Environmental Health (NCEH) of CDC within HHS is committed to
achieving the health promotion and disease prevention objectives of Healthy People 2020 found
at: https://www.healthypeople.gov/. This NOFO is committed to the Healthy People 2020 leadrelated goals of reducing: (1) blood lead levels above CDC's reference value, and (2) mean
blood lead levels in young children, as well as disparities in blood lead levels based on race,
ethnicity, and socioeconomic status, as public health concerns. This NOFO addresses the
Healthy People 2020 topics of Maternal, Infant, and Child Health; Injury and Violence Preve
ntion; and Environmental Health.
d. Other National Public Health Priorities and Strategies
This NOFO also supports the National Prevention Strategy's Healthy and Safe Community
Environments. Additional information can be found at: https:// www.surgeongeneral.gov/ prior
ities/ prevention/ strategy/ healthy-and- safe-community-environments.html
e. Relevant Work
The Lead Contamination Control Act of 1988 authorized the Centers for Disease Control and
Prevention (CDC) to initiate program efforts to eliminate childhood lead poisoning in the
United States. The CDC Childhood Lead Poisoning Prevention Program was created as a result
of this act. From 1990 to 2012, CDC awarded funds to state and local health departments to
support childhood lead poisoning prevention programs. In FY14 and FY17, CDC awarded 3year funding for lead poisoning prevention strategic programmatic activities under CDC-RFAEH14-1408PPHF14 and CDC-RFA-EH17-1701PPHF17, respectively. This NOFO directly
builds on these programs and includes the same four strategic activities as CDC-RFA-EH171707PPHF17.
2. CDC Project Description
a. Approach
Bold indicates period of performance outcome.

3 of 48

i. Purpose

4 of 48
This funding is intended to support activities to reduce childhood lead exposure and lead
poisoning activities including: blood lead testing, surveillance, and targeted population-based
interventions. Recipients will also be expected to demonstrate that processes are in place to

i. Purpose
This funding is intended to support activities to reduce childhood lead exposure and lead
poisoning including strengthening: blood lead testing, surveillance, and targeted populationbased interventions. Recipients will also be expected to demonstrate that processes are in place
to identify lead-exposed children and link them to recommended services. Recipients will be
expected to work closely with agencies and other stakeholders serving children to ensure that
a system of blood lead testing, case management, referral, follow-up,
surveillance/monitoring, and evaluation is in place.
ii. Outcomes
Recipients are expected to achieve and report the following short-term outcomes during the
Period of Performance:
1. Increase the number of children less than 6 years (72 months) of age tested for
blood lead.
2. Improve data usage that leads to a greater identification of geographic areas and
populations at high-risk for lead exposed children.
3. Increase the ability to target interventions (e.g. education and outreach) to highrisk geographic areas and populations.
4. Increase the identification of children exposed to lead and link them to
recommended services.
iii. Strategies and Activities
Applicants must use childhood lead poisoning prevention funding to accomplish the following
four activities.
Strengthen Blood Lead Level Testing
In support of blood lead level testing, applicants should:
 Develop and implement a plan for increasing blood lead testing of children less than 6
years (72 months) of age.
 Develop and implement blood lead testing strategies, with special emphasis on
achieving universal testing of Medicaid-enrolled children.
Strengthen Surveillance
Applicants are expected to implement a childhood lead poisoning surveillance system that can
report to CDC quarterly on the number of children who are exposed to lead in housing, the
number of houses that are identified with lead, and the nature and extent of lead in housing. In
addition applicants must:
 Develop, implement, and maintain a blood lead surveillance system that will collect,
compile, and track blood lead data and lead hazards data.
 Develop and implement a blood lead data collection, data quality and dissemination
plan. Conduct analyses of surveillance data.

5 of 48

 Establish and implement surveillance reporting system and dissemination plan. Include
information on how data will be collected, evaluated, reported, shared with partners, and
disseminated to the public.
Surveillance data collection efforts should maximally leverage existing tools and systems and
should adhere to national data and technology standards to support interoperability of systemto-system data exchange.
Strengthen Population-based Interventions
The following are population-based intervention activities that applicants should consider:
 Develop and implement targeted population-based interventions. Educate public,
partners, and stakeholders about lead-related issues.
 Develop and conduct trainings for lead workforce, partners, and other stakeholders.
 Develop and maintain collaborative relationships with community, local, and state
partners and stakeholders to address priority challenges and opportunities.
To assist in the development and implementation of appropriate interventions, collected data
shall integrate or interface with other:
Maternal child and environmental public health databases (e.g., immunization registries; Adult
Blood Lead Epidemiology and Surveillance [ABLES]; National Electronic Disease Surveillance
System [NEDSS]; Environmental Public Health Tracking Network; Medicaid; and Special
Supplemental Nutrition Program for Women, Infants and Children [WIC]); State and local
housing and environmental quality authorities; and Housing data including that for housing
code enforcement agencies and publicly owned or subsidized properties and Housing and Urban
Development (HUD) collaborative programs.
Strengthen processes to identify lead-exposed children and linkage to services
The following activities should be considered in support of identifying lead-exposed children
and linking them to services:
 Provide technical support and subject matter expertise to systems that identify, refer,
provide services to, and follow lead-exposed children.
 Organize regular meetings with partners, stakeholders, and programs (e.g., early
childhood education programs, social services, school systems, etc.) that can provide
services to mitigate the effects of high blood lead levels.
 Connect lead-exposed children to services.
 Conduct education and outreach to parents and providers of lead-exposed children and
those who are considered at-risk.
*The program should ensure that recipients adequately and appropriately inform the public that
such education and outreach (mass communication campaigns) were supported with Federal
dollars (if applicable).
*Applicants shall use education and outreach activities to raise awareness about lead-related
issues and are explicitly prohibited from using Federal dollars for lobbying purposes.

6 of 48

1. Collaborations
a. With other CDC programs and CDC-funded organizations:
Applicants should engage other CDC-funded programs in their jurisdictions, particularly those
with a focus on child health and/or environmental health, and leverage opportunities to reach
targeted populations, share databases, deliver services, and achieve outcomes expected under
this NOFO. Applicants must file the MOU or MOA, as appropriate, name the file
"MOUs/MOAs" and upload it as a PDF at grants.gov.
Examples of other CDC-funded programs include, but are not limited, to:
 Environmental Public Health Tracking Program http://www.cdc.gov/nceh/tracking/
 National Institute of Occupational Safety and Health?s Adult Blood Lead Epidemiology
Program (ABLES) https://www.cdc.gov/niosh/topics/ables/
 State and local immunization and asthma programs and registries
 National Center for Birth Defects and Developmental Disabilities (NCBDDD) programs
and registries
 Agency of Toxic Substances and Disease Registry's ATSDR's Partnership to Promote
Local Efforts to Reduce Environmental Exposure (APPLETREE) grantees
(https://www.atsdr.cdc.gov/states/index.html) or other local/state/regional ATSDR
activities or assessments (https://www.atsdr.cdc.gov/dro/index/html).
b. With organizations not funded by CDC:
Applicants should work with relevant organizations external to CDC that could extend their
reach to targeted populations, interface with other databases, and help facilitate activities under
this NOFO. Letters of support/Memorandums of Understanding/Memorandums of Agreement
stating agreed upon area of collaboration from relevant state officials and others should be
included in the application.
Examples of such organizations are:















U.S Department of Housing and Urban Development (HUD)
Centers for Medicare and Medicaid Services (CMS)
Special Supplemental Nutrition Program for Women, Infants and Children (WIC)
U.S. Environmental Protection Agency (EPA)
HRSA Title V recipients
HRSA Federal Home Visiting Program
HRSA Healthy Start Program
Maternal and child health programs
Early childhood education programs
Community-based, nonprofit and/or faith-based organizations
State and local health and housing agencies
Private and public laboratories
Hospitals and healthcare systems
Academic institutions

7 of 48

 Accredited environmental health practitioners and their organizations
Strategies should be implemented for leveraging resources that include funds from other
allowable federally funded programs and/or state, local, charity, nonprofit or for-profit entities,
or internal agency resources.
Applicants are expected to create a capacity-building mechanism, with partners, that will
provide training, education, technical support, mobilization, and consensus to improve the
communities? ability to detect lead sources and identify risks and provide appropriate and
timely interventions.
2. Target Populations
The target population for this program is children less than 6 years (72 months) of age. Priority
should be given to children disproportionately affected by lead exposures and lead poisoning,
particularly those living in areas that include homes built before 1978, low-income or
subsidized housing with suspected or known lead hazards, racial and ethnic minorities, and
recent immigrants. Medicaid-enrolled children represent a high-risk target population.
a. Health Disparities
Applicants should consider under-served populations, including tribal, disabled, and English
speakers of other languages (ESOL), as well as other populations, to ensure they benefit from
the applicants? childhood lead poisoning prevention activities.
iv. Funding Strategy
Not Applicable.
b. Evaluation and Performance Measurement
i. CDC Evaluation and Performance Measurement Strategy
Evaluation and progress reports
Prepare a written assessment of the accomplishments, challenges and opportunities including a
description of the problems encountered, lessons learned, potential improvements.
Strategies/Activities:
1) Strengthen Blood Lead Level Testing: Implement a plan for blood lead testing of children
less than 6 years (72 months) of age.
 Indicators for success: a completed blood lead testing plan that includes an emphasis on
universal testing of Medicaid-enrolled children.
2) Strengthen Surveillance: Implement a surveillance reporting system and dissemination plan.
Include information on how data will be collected, evaluated, reported, shared with partners,
and disseminated to the public.
 Indicators for success: establishment and operation of an active ongoing sustainable
childhood lead poisoning surveillance/tracking system in recipients? jurisdictions that
8 of 48

collects person-specific and address-specific data, including multiple laboratory test
results over various years and that assures the periodic screening of children who are
exposed to lead; a completed surveillance plan outlining approaches for data collection,
evaluation, timely reporting, and data sharing to both partners and the public.
 Recipient's collection of sensitive data must be completed in accordance with all
applicable privacy laws at both the state and federal level.
3) Strengthen Population-based Interventions: maintain collaborative relationships with
community, local, and state partners and stakeholders to address priority childhood lead
poisoning prevention challenges and opportunities.
 Indicators for success: documentation of ongoing community and partners/stakeholder
meetings; completed examples of lead prevention education and training materials;
implementation of a process that ensures data is received and used by federal agencies
and public health officials to target actions to areas where the risk for childhood lead
poisoning is the highest.
4) Strengthen processes to identify lead-exposed children and linkage to services:
 Indicators for success: implementation of a process that identifies lead-exposed children,
provides guidance for the referral and follow-up care of children, and evaluates the
timeliness and efficacy of these activities.
Outcomes:
1) Increased numbers of children less than 6 years (72 months) of age tested for blood lead.
Indicators for success include:
 Increase in the percentage of children less than 6 years (72 months) of age tested for
blood lead from the previous reporting period;
 Increase in the percentage of Medicaid-enrolled children less than 6 years (72 months)
of age tested for blood lead since the previous reporting period.
Percent of Medicaid-enrolled one year-old children tested for blood lead levels during
the reporting period
[calculation: (number of Medicaid-enrolled one year-old children tested for blood
lead levels / total number of Medicaid-enrolled one year-old children in the
jurisdiction)*100]
Percent of Medicaid-enrolled two year-old children tested for blood lead levels during
the reporting period
[calculation: (number of Medicaid-enrolled two year-old children tested for blood
lead levels / total number of Medicaid-enrolled two year-old children in the
jurisdiction)*100]
Percent of all one and two year-old children (both Medicaid-enrolled and nonMedicaid-enrolled) tested for blood lead levels in the previous calendar year

9 of 48

[calculation: (number of children aged one and two years tested for blood lead in
the previous calendar year / total number of children under three years of age in
the jurisdiction in the previous calendar year)*100]
2) Improved availability and use of data that leads to improved identification of geographic
areas and populations at high risk for lead
Indicators for success include:
 95% of Recipients' surveillance data received by CDC is free of errors and missing
information;
 Resources (e.g., GIS software) and data (e.g., blood lead surveillance, census, and tax
assessor data) are used to analyze and report information;
 The program is able to maintain 100% electronic reporting of blood lead data from
laboratories.
Percent of laboratory-reported blood lead test results that are reported electronically
[calculation: (number of laboratory-reported blood lead test results that are
electronically reported / total number of laboratory-reported blood lead test results
received during the reporting period)*100]
3) Increased ability to target population-based interventions to high-risk geographic areas and
populations.
Indicators for success:
 Community based partners (health care providers, grass roots organizations,
nongovernment organizations [NGOs], others) and/or universities/colleges agree to
participate in preparing for and assisting in population-based surveillance and targeted
interventions.
Number of new partner organizations and institutions engaged in brainstorming,
strategizing, planning, implementing, or evaluating interventions for lead
poisoning prevention in targeted geographic areas during the reporting period
Number of new partner organizations and institutions engaged in brainstorming,
strategizing, planning, implementing, or evaluating interventions for lead
poisoning prevention for targeted at-risk populations (to include low-income and
immigrant/refugee children) during the reporting period
Number of regularly scheduled and held meetings with partners and stakeholders
during the reporting period
Number of new memoranda of understanding or equivalent documents like
memoranda of agreement and joint work plans - related to population-based
childhood lead surveillance enhancement and targeted interventions for lead
poisoning prevention developed and signed during the reporting period
Number of new data-sharing agreements for enhanced population-based
childhood lead surveillance developed and signed during the reporting period

10 of 48

4) Increased identification of lead-exposed children who receive appropriate linkages to
recommended follow-up services.
Indicators for success:
 Implementation of a process that identifies lead-exposed children, provides guidance for
the referral and follow-up care of children with elevated BLLs, and evaluates the
timeliness and efficacy of these activities.
Number of public health professionals and clinical providers who received
guidance documents for follow-up care for children who are identified with
elevated blood lead levels during the reporting period
Percent of children less than 6 years (72 months) of age who are referred to or
from your Program for recommended follow-up services within two weeks of a
confirmed elevated blood lead test result during the reporting period
[calculation: (number of children with elevated blood lead levels referred for
follow-up services / number of children with elevated blood lead
levels)*100]
Percent of children less than 6 years (72 months) of age who received
recommended follow-up services within two weeks of a referral for recommended
follow-up services following a confirmed elevated blood lead test result during
the reporting period
[calculation: (number of children with elevated blood lead levels who
received referred follow-up services / number of children with elevated blood
lead levels referred for follow-up services)*100]
ii. Applicant Evaluation and Performance Measurement Plan
Applicants must provide an evaluation and performance measurement plan that demonstrates
how the recipient will fulfill the requirements described in the CDC Evaluation and
Performance Measurement and Project Description sections of this NOFO. At a minimum, the
plan must describe:
 How applicant will collect the performance measures, respond to the evaluation
questions, and use evaluation findings for continuous program quality improvement.
 How key program partners will participate in the evaluation and performance
measurement planning processes.
 Available data sources, feasibility of collecting appropriate evaluation and performance
data, and other relevant data information (e.g., performance measures proposed by the
applicant)
 Plans for updating the Data Management Plan (DMP), if applicable, for accuracy
throughout the lifecycle of the project. The DMP should provide a description of the
data that will be produced using these NOFO funds; access to data; data standards
ensuring released data have documentation describing methods of collection, what the
data represent, and data limitations; and archival and long-term data preservation plans.
For more information about CDC’s policy on the DMP, see
11 of 48

https://www.cdc.gov/grants/additionalrequirements/ar-25.html.
Where the applicant chooses to, or is expected to, take on specific evaluation studies, they
should be directed to:
 Describe the type of evaluations (i.e., process, outcome, or both).
 Describe key evaluation questions to be addressed by these evaluations.
 Describe other information (e.g., measures, data sources).
Recipients will be required to submit a more detailed Evaluation and Performance Measurement
plan, including a DMP, if applicable, within the first 6 months of award, as described in the
Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach
The organizational capacity statement should describe how the applicant agency is organized to
carry out the requirements of this announcement, the nature and scope of its work, and/or its
capabilities. Applicants should include a detailed description of their experience in collecting,
analyzing, and reporting data; implementing surveillance systems; targeting prevention
activities to high risk areas; and managing programs and staff. They should also describe their
working agreements, as well as letters of intent or contracts with partners.
Applicants should provide an organizational chart and curriculm vitae for key personnel. Key
personnel must have the level of education, experience, and/or skills necessary to successfully
implement and complete the project.
Additional information includes the following:
 Organizational chart
 Curriculum vitae for existing key personnel (or job descriptions for planned key
personnel)
 Indirect cost rate agreements
 Letters of support
The applicant must create a separate file for the noted items and must name the file
"Organizational Chart","CVs/Resumes," "Indirect Cost Rate Agreements," and "Letters of
Support" and upload to www.grants.gov.
d. Work Plan
A work plan is a program management tool that provides program direction and guidance. It
allows the project officer to monitor implementation of activities on progress on Period of
Performance outcomes.
Applicants must have a work plan. No specific work plan template is required as long as it is
clear how the components in the work plan crosswalk to the strategies and activities, outcomes,
and evaluation performance measures presented in the logic model and the narrative sections of

12 of 48

this NOFO.
Applicants must provide a separate detailed work plan of no more than 5 pages to describe work
to be conducted in the first year of this award. A high-level work plan of no more than 5 pages
should be included separately to describe work to be conducted in year two of the award.
A sample work plan format is presented below.
Sample Work Plan
Short-term Outcome 1:
Increased number of children less than 6 years (72 months) of age tested for blood lead
Strategies
Process Measure Status
and Activities

Baseline Target Responsible
Position /
Person

Target
Completion
Date

Develop and Plan for blood lead Completed N/A
implement
testing is completed
plan for blood
lead testing of
children

N/A

Epidemiologist 09/29/2019
and Program
Manager

Develop and Number of
In progress 1
maintain
community and
collaborative partner/stakeholder
relationships meetings
with
community,
local, and state
partners and
stakeholders
to address
priority
challenges and
opportunities

4

Program
Manager

09/29/2019

Develop and Number of
Not started 0
maintain
memorandum of
collaborative agreements (MOU)
relationships or signed
with
community,
local, and state
partners and
stakeholders

1

Program
Manager

09/29/2019

13 of 48

to address
priority
challenges and
opportunities
e. CDC Monitoring and Accountability Approach
Monitoring activities include routine and ongoing communication between CDC and recipients,
site visits, and recipient reporting (including work plans, performance, and financial reporting).
Consistent with applicable grants regulations and policies, CDC expects the following to be
included in post-award monitoring for grants and cooperative agreements:
 Tracking recipient progress in achieving the desired outcomes.
 Ensuring the adequacy of recipient systems that underlie and generate data reports.
 Creating an environment that fosters integrity in program performance and results.
Monitoring may also include the following activities deemed necessary to monitor the award:
 Ensuring that work plans are feasible based on the budget and consistent with the intent
of the award.
 Ensuring that recipients are performing at a sufficient level to achieve outcomes
within stated timeframes.
 Working with recipients on adjusting the work plan based on achievement of
outcomes, evaluation results and changing budgets.
 Monitoring performance measures (both programmatic and financial) to assure
satisfactory performance levels.
Monitoring and reporting activities that assist grants management staff (e.g., grants management
officers and specialists, and project officers) in the identification, notification, and management
of high-risk recipients.

f. CDC Program Support to Recipients (THIS SECTION APPLIES ONLY TO
COOPERATIVE AGREEMENTS)
CDC and recipients share responsibility for successfully implementing the award and meeting
identified outcomes. The following are potential areas of substantial CDC involvement, others
may also be included:
i. CDC will provide Technical Assistance:
 Provide subject matter expertise to support recipients in the development or
enhancement and implementation of blood lead surveillance systems.
 Provide subject matter expertise to support recipients in the development or
enhancement of evaluation and performance measurement and program effectiveness.
 Provide subject matter expertise to support recipients in the development or
enhancement of work plans, program planning, and capacity building.

14 of 48

ii. CDC will support Information Sharing between Recipients:
 Support information sharing of "best practices" and "lessons learned" through required
annual recipient meetings and quarterly conference calls, and at other venues, as
appropriate.
 Provide access to information-sharing portals (e.g., sharepoint site).
 Promote the use of "Success Stories" and other reports and publications.
iii. CDC will provide Additional Support:
 Provide Healthy Homes and Lead Poisoning Software System (HHLPSS) at no cost to
support recipients in deployment of the system and migration of data from other systems
to HHLPSS.
 Review the use of data and information collected to support development, enhancement
or implementation of population-based interventions.
 Provide guidance in implementing activities, and will identify major program issues,
strategies, and priorities related to the cooperative agreement.
 Promote collaboration with other federal, state, and local health; environmental; and
housing agencies by initiating contacts, conference calls, and on-site visits to discuss
programmatic issues.
 Provide consultation and technical assistance regarding approaches used to links
children to appropriate services.

B. Award Information
1. Funding Instrument Type:

2. Award Mechanism:

Cooperative Agreement
CDC's substantial involvement in this
program appears in the CDC Program
Support to Recipients Section.
UE2

3. Fiscal Year:
4. Approximate Total Fiscal Year Funding:
5. Approximate Period of Performance Funding:

2018
$5,000,000
$10,000,000

This amount is subject to the availability of funds.
Estimated Total Funding:
6. Approximate Period of Performance Length:
7. Expected Number of Awards:

$10,000,000
2 year(s)
10

8. Approximate Average Award:

$400,000 Per Budget Period

9. Award Ceiling:

$500,000 Per Budget Period

15 of 48

This amount is subject to the availability of funds.
10. Award Floor:

$200,000 Per Budget Period

11. Estimated Award Date:
12. Budget Period Length:

09/30/2018
12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds,
the evidence of satisfactory progress by the recipient (as documented in required reports), and
the determination that continued funding is in the best interest of the federal government. The
total number of years for which federal support has been approved (project period) will be
shown in the “Notice of Award.” This information does not constitute a commitment by the
federal government to fund the entire period. The total period of performance comprises the
initial competitive segment and any subsequent non-competitive continuation award(s).
13. Direct Assistance
Direct Assistance (DA) is not available through this FOA.

C. Eligibility Information
1. Eligible Applicants
Eligibility Category:

Others (see text field entitled "Additional
Information on Eligibility" for
clarification)

Additional Eligibility Category:
Government Organizations:
State governments or their bona fide
agents (includes the District of
Columbia)
Local governments or their bona fide
agents
Territorial governments or their bona
fide agents in the Commonwealth of
Puerto Rico, the Virgin Islands, the
Commonwealth of the Northern
Marianna Islands, American Samoa,
Guam, the Federated States of
Micronesia, the Republic of the Marshall
Islands, and the Republic of Palau.
American Indian or Alaska Native tribal
16 of 48

governments (federally recognized or
state-recognized)
2. Additional Information on Eligibility
Government Organizations: State, Local, Territorial (including the District of Columbia, the
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern
Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of
the Marshall Islands, and the Republic of Palau), or Tribal (federally recognized or staterecognized American Indian or Alaska Native) Governments, or their Bona Fide Agents.
Local Governments must represent a valid population size of at least 750,000 using U.S.
Census data or a 2011-2017 U.S. Census data update.
This NOFO is limited to State, Local, Territorial, or Tribal Governments, or their Bona Fide
Agents that have not already received or been approved for funding under CDC-RFA-EH171701PPHF17.
This Notice of Funding Opportunity (NOFO) is to support activities under the authority of:
Sections 317(k)(2) and 317(A) of the Public Health Service Act, (42 U.S.C. Sections
247b(k)(2) and 247b-3(b)), as amended. This NOFO supports activities related to lead
poisoning prevention with a focus on using blood surveillance data to identify and implement
appropriate interventions to populations at highest risk. Recipients must be able to assure that
follow-up is provided for lead-exposed children. Therefore, recipients must have the authority
in their jurisdiction(s) to govern, regulate, deliver, implement, and enforce policies, codes or
requirements on childhood lead poisoning prevention that could involve Medicaid, housing,
environmental regulation, medical laboratory, or consumer protection agencies. State, Local,
Territorial, or Tribal governments, or their Bona Fide Agents, are the only entities with the
broad authorities to achieve the mission of this NOFO.

3. Justification for Less than Maximum Competition
Not Applicable
4. Cost Sharing or Matching
Cost Sharing / Matching Requirement:
No
No cost sharing or matching funds are required for this program. Although no statutory
matching requirement for this NOFO exists, leveraging other resources and related ongoing
efforts to promote sustainability is strongly encouraged.
5. Maintenance of Effort
Maintenance of effort is not required for this program.
D. Application and Submission Information
1. Required Registrations
17 of 48

An organization must be registered at the three following locations before it can submit an
application for funding at www.grants.gov.
a. Data Universal Numbering System:
All applicant organizations must obtain a Data Universal Numbering System (DUNS) number.
A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet
(D&B). It will be used as the Universal Identifier when applying for federal awards or
cooperative agreements.
The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll
free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS
number will be provided at no charge.
If funds are awarded to an applicant organization that includes sub-recipients, those subrecipients must provide their DUNS numbers before accepting any funds.
b. System for Award Management (SAM):
The SAM is the primary registrant database for the federal government and the repository into
which an entity must submit information required to conduct business as a recipient. All
applicant organizations must register with SAM, and will be assigned a SAM number. All
information relevant to the SAM number must be current at all times during which the applicant
has an application under consideration for funding by CDC. If an award is made, the SAM
information must be maintained until a final financial report is submitted or the final payment is
received, whichever is later. The SAM registration process can require 10 or more business
days, and registration must be renewed annually. Additional information about registration
procedures may be found at www.SAM.gov.
c. Grants.gov:
The first step in submitting an application online is registering your organization
at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the
"Applicant Registration" option at www.grants.gov.
All applicant organizations must register at www.grants.gov. The one-time registration process
usually takes not more than five days to complete. Applicants should start the registration
process as early as possible.
Step System
1
Data
Universal
Number
System
(DUNS)

Requirements
Duration
1. Click on http://
1-2 Business
fedgov.dnb.com/ webform Days
2. Select Begin DUNS
search/request process
3. Select your country or
territory and follow the
instructions to obtain your
DUNS 9-digit #
4. Request appropriate
staff member(s) to obtain
DUNS number, verify &
update information under

Follow Up
To confirm that
you have been
issued a new
DUNS number
check online at
(http://
fedgov.dnb.com/
webform) or call
1-866-705-5711

18 of 48

2

3

DUNS number
System for 1. Retrieve organizations
Award
DUNS number
Management 2. Go to www.sam.gov
(SAM)
and designate an E-Biz
formerly
POC (note CCR username
Central
will not work in SAM and
Contractor you will need to have an
Registration active SAM account
(CCR)
before you can register on
grants.gov)
Grants.gov 1. Set up an individual
account in Grants.gov
using organization new
DUNS number to become
an authorized organization
representative (AOR)
2. Once the account is set
up the E-BIZ POC will be
notified via email
3. Log into grants.gov
using the password the EBIZ POC received and
create new password
4. This authorizes the
AOR to submit
applications on behalf of
the organization

3-5 Business
Days but up
to 2 weeks
and must be
renewed
once a year

For SAM
Customer
Service Contact
https://fsd.gov/
fsd-gov/
home.do Calls:
866-606-8220

Same day but Register early!
can take 8 Log into
weeks to be grants.gov and
fully
check AOR
registered
status until it
and approved shows you have
in the system been approved
(note,
applicants
MUST
obtain a
DUNS
number and
SAM
account
before
applying on
grants.gov)

2. Request Application Package
Applicants may access the application package at www.grants.gov.
3. Application Package
Applicants must download the SF-424, Application for Federal Assistance, package associated
with this notice of funding opportunity at www.grants.gov. If Internet access is not available, or
if the online forms cannot be accessed, applicants may call the CDC OGS staff at 770-4882700 or e-mail OGS ogstims@cdc.gov for assistance. Persons with hearing loss may access
CDC telecommunications at TTY 1-888-232-6348.
4. Submission Dates and Times
If the application is not submitted by the deadline published in the NOFO, it will not be
processed. Office of Grants Services (OGS) personnel will notify the applicant that their
application did not meet the deadline. The applicant must receive pre-approval to submit a paper
application (see Other Submission Requirements section for additional details). If the applicant

19 of 48

is authorized to submit a paper application, it must be received by the deadline provided by
OGS.
a. Letter of Intent Deadline (must be emailed or postmarked by)
Due Date for Letter of Intent: N/A
b. Application Deadline
Due Date for Applications: 08/09/2018 , 11:59 p.m. U.S. Eastern Standard Time, at
www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances
preclude advance notification of an extension, then applications must be submitted by the first
business day on which grants.gov operations resume.
Date for Information Conference Call
An informational conference call will occur on Tuesday, July 17, 2018, from 2 to 3 p.m. eastern
standard time. Call-in information is 855-644-0229, conference ID 6530827
Updated details about the informational call will be posted at: https://www.cdc.gov/nceh/lead/
5. CDC Assurances and Certifications
All applicants are required to sign and submit “Assurances and Certifications” documents
indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))
/Homepage.aspx.
Applicants may follow either of the following processes:
 Complete the applicable assurances and certifications with each application submission,
name the file “Assurances and Certifications” and upload it as a PDF file with at
www.grants.gov
 Complete the applicable assurances and certifications and submit them directly to CDC
on an annual basis at http://wwwn.cdc.gov/ grantassurances/
(S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx
Assurances and certifications submitted directly to CDC will be kept on file for one year and
will apply to all applications submitted to CDC by the applicant within one year of the
submission date.
Risk Assessment Questionnaire Requirement
CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses
to meeting federal programmatic and administrative requirements by taking into account issues
such as financial instability, insufficient management systems, non-compliance with award
conditions, the charging of unallowable costs, and inexperience. The risk assessment will
include an evaluation of the applicant’s CDC Risk Questionnaire, located at
https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a
review of the applicant’s history in all available systems; including OMB-designated
repositories of government-wide eligibility and financial integrity systems (see 45 CFR
75.205(a)), and other sources of historical information. These systems include, but are not
20 of 48

limited to: FAPIIS (https://www.fapiis.gov/), including past performance on federal contracts as
per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System
for Award Management (SAM) exclusions.
CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 09201132 annually. This questionnaire, which is located at
https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with
supporting documentation must be submitted with your application by the closing date of the
Notice of Funding Opportunity Announcement. If your organization has completed CDC’s
Risk Questionnaire within the past 12 months of the closing date of this NOFO, then you must
submit a copy of that questionnaire, or submit a letter signed by the authorized organization
representative to include the original submission date, organization’s EIN and DUNS.
When uploading supporting documentation for the Risk Questionnaire into this application
package, clearly label the documents for easy identification of the type of documentation. For
example, a copy of Procurement policy submitted in response to the questionnaire may be
labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement
Policy.
Duplication of Efforts
Applicants are responsible for reporting if this application will result in programmatic,
budgetary, or commitment overlap with another application or award (i.e. grant, cooperative
agreement, or contract) submitted to another funding source in the same fiscal year.
Programmatic overlap occurs when (1) substantially the same project is proposed in more than
one application or is submitted to two or more funding sources for review and funding
consideration or (2) a specific objective and the project design for accomplishing the objective
are the same or closely related in two or more applications or awards, regardless of the funding
source. Budgetary overlap occurs when duplicate or equivalent budgetary items (e.g.,
equipment, salaries) are requested in an application but already are provided by another source.
Commitment overlap occurs when an individual’s time commitment exceeds 100 percent,
whether or not salary support is requested in the application. Overlap, whether programmatic,
budgetary, or commitment of an individual’s effort greater than 100 percent, is not permitted.
Any overlap will be resolved by the CDC with the applicant and the PD/PI prior to award.
Report Submission: The applicant must upload the report in Grants.gov under “Other
Attachment Forms.” The document should be labeled: "Report on Programmatic, Budgetary,
and Commitment Overlap.”

6. Content and Form of Application Submission
Applicants are required to include all of the following documents with their application package
at www.grants.gov.
7. Letter of Intent
Not Applicable
8. Table of Contents
(There is no page limit. The table of contents is not included in the project narrative page

21 of 48

limit.): The applicant must provide, as a separate attachment, the “Table of Contents” for the
entire submission package.
Provide a detailed table of contents for the entire submission package that includes all of the
documents in the application and headings in the "Project Narrative" section. Name the file
"Table of Contents" and upload it as a PDF file under "Other Attachment Forms"
at www.grants.gov.
9. Project Abstract Summary
(Maximum 1 page)
A project abstract is included on the mandatory documents list and must be submitted
at www.grants.gov. The project abstract must be a self-contained, brief summary of the
proposed project including the purpose and outcomes. This summary must not include any
proprietary or confidential information. Applicants must enter the summary in the "Project
Abstract Summary" text box at www.grants.gov.

10. Project Narrative
(Unless specified in the "H. Other Information" section, maximum of 20 pages, single spaced,
12 point font, 1-inch margins, number all pages. This includes the work plan. Content beyond
the specified page number will not be reviewed.)
Applicants must submit a Project Narrative with the application forms. Applicants must name
this file “Project Narrative” and upload it at www.grants.gov. The Project Narrative must
include all of the following headings (including subheadings): Background, Approach,
Applicant Evaluation and Performance Measurement Plan, Organizational Capacity of
Applicants to Implement the Approach, and Work Plan. The Project Narrative must be succinct,
self-explanatory, and in the order outlined in this section. It must address outcomes and
activities to be conducted over the entire period of performance as identified in the CDC Project
Description section. Applicants should use the federal plain language guidelines and Clear
Communication Index to respond to this Notice of Funding Opportunity. Note that recipients
should also use these tools when creating public communication materials supported by this
NOFO. Failure to follow the guidance and format may negatively impact scoring of the
application.
a. Background
Applicants must provide a description of relevant background information that includes the
context of the problem (See CDC Background).
b. Approach
i. Purpose
Applicants must describe in 2-3 sentences specifically how their application will address the
public health problem as described in the CDC Background section.
ii. Outcomes
Applicants must clearly identify the outcomes they expect to achieve by the end of the project
22 of 48

period, as identified in the logic model in the Approach section of the CDC Project Description.
Outcomes are the results that the program intends to achieve and usually indicate the intended
direction of change (e.g., increase, decrease).
iii. Strategies and Activities
Applicants must provide a clear and concise description of the strategies and activities they will
use to achieve the period of performance outcomes. Applicants must select existing evidencebased strategies that meet their needs, or describe in the Applicant Evaluation and Performance
Measurement Plan how these strategies will be evaluated over the course of the project period.
See the Strategies and Activities section of the CDC Project Description.
1. Collaborations
Applicants must describe how they will collaborate with programs and organizations either
internal or external to CDC. Applicants must address the Collaboration requirements as
described in the CDC Project Description.
2. Target Populations and Health Disparities
Applicants must describe the specific target population(s) in their jurisdiction and explain how
such a target will achieve the goals of the award and/or alleviate health disparities. The
applicants must also address how they will include specific populations that can benefit from
the program that is described in the Approach section. Applicants must address the Target
Populations and Health Disparities requirements as described in the CDC Project Description.

c. Applicant Evaluation and Performance Measurement Plan
Applicants must provide an evaluation and performance measurement plan that demonstrates
how the recipient will fulfill the requirements described in the CDC Evaluation and
Performance Measurement and Project Description sections of this NOFO. At a minimum, the
plan must describe:
 How applicant will collect the performance measures, respond to the evaluation
questions, and use evaluation findings for continuous program quality improvement. The
Paperwork Reduction Act of 1995 (PRA): Applicants are advised that any activities
involving information collections (e.g., surveys, questionnaires, applications, audits,
data requests, reporting, recordkeeping and disclosure requirements) from 10 or more
individuals or non-Federal entities, including State and local governmental agencies, and
funded or sponsored by the Federal Government are subject to review and approval by
the Office of Management and Budget. For further information about CDC’s
requirements under PRA see http://www.hhs.gov/ ocio/policy/collection/.
 How key program partners will participate in the evaluation and performance
measurement planning processes.
 Available data sources, feasibility of collecting appropriate evaluation and performance
data, data management plan (DMP), and other relevant data information (e.g.,

23 of 48

performance measures proposed by the applicant).
Where the applicant chooses to, or is expected to, take on specific evaluation studies, they
should be directed to:
 Describe the type of evaluations (i.e., process, outcome, or both).
 Describe key evaluation questions to be addressed by these evaluations.
 Describe other information (e.g., measures, data sources).
Recipients will be required to submit a more detailed Evaluation and Performance Measurement
plan (including the DMP elements) within the first 6 months of award, as described in the
Reporting Section of this NOFO.

d. Organizational Capacity of Applicants to Implement the Approach
Applicants must address the organizational capacity requirements as described in the CDC
Project Description.

11. Work Plan
(Included in the Project Narrative’s page limit)
Applicants must prepare a work plan consistent with the CDC Project Description Work Plan
section. The work plan integrates and delineates more specifically how the recipient plans to
carry out achieving the period of performance outcomes, strategies and activities, evaluation
and performance measurement.

12. Budget Narrative
Applicants must submit an itemized budget narrative. When developing the budget narrative,
applicants must consider whether the proposed budget is reasonable and consistent with the
purpose, outcomes, and program strategy outlined in the project narrative. The budget must
include:











Salaries and wages
Fringe benefits
Consultant costs
Equipment
Supplies
Travel
Other categories
Contractual costs
Total Direct costs
Total Indirect costs

24 of 48

Indirect costs could include the cost of collecting, managing, sharing and preserving data.
Indirect costs on grants awarded to foreign organizations and foreign public entities and
performed fully outside of the territorial limits of the U.S. may be paid to support the costs of
compliance with federal requirements at a fixed rate of eight percent of MTDC exclusive of
tuition and related fees, direct expenditures for equipment, and subawards in excess of $25,000.
Negotiated indirect costs may be paid to the American University, Beirut, and the World Health
Organization.
If applicable and consistent with the cited statutory authority for this announcement, applicant
entities may use funds for activities as they relate to the intent of this NOFO to meet national
standards or seek health department accreditation through the Public Health Accreditation
Board (see: http://www.phaboard.org). Applicant entities to whom this provision applies
include state, local, territorial governments (including the District of Columbia, the
Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern
Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of
the Marshall Islands, and the Republic of Palau), or their bona fide agents, political subdivisions
of states (in consultation with states), federally recognized or state-recognized American Indian
or Alaska Native tribal governments, and American Indian or Alaska Native tribally designated
organizations. Activities include those that enable a public health organization to deliver public
health services such as activities that ensure a capable and qualified workforce, up-to-date
information systems, and the capability to assess and respond to public health needs. Use of
these funds must focus on achieving a minimum of one national standard that supports the
intent of the NOFO. Proposed activities must be included in the budget narrative and must
indicate which standards will be addressed.
Applicants must name this file “Budget Narrative” and upload it as a PDF file
at www.grants.gov. If requesting indirect costs in the budget, a copy of the indirect cost-rate
agreement is required. If the indirect costs are requested, include a copy of the current
negotiated federal indirect cost rate agreement or a cost allocation plan approval letter for
those Recipients under such a plan. Applicants must name this file “Indirect Cost Rate” and
upload it at www.grants.gov.

13. Funds Tracking
Proper fiscal oversight is critical to maintaining public trust in the stewardship of federal funds.
Effective October 1, 2013, a new HHS policy on subaccounts requires the CDC to set up
payment subaccounts within the Payment Management System (PMS) for all new grant awards.
Funds awarded in support of approved activities and drawdown instructions will be identified
on the Notice of Award in a newly established PMS subaccount (P subaccount). Recipients will
be required to draw down funds from award-specific accounts in the PMS. Ultimately, the
subaccounts will provide recipients and CDC a more detailed and precise understanding of
financial transactions. The successful applicant will be required to track funds by Paccounts/sub accounts for each project/cooperative agreement awarded. Applicants are
encouraged to demonstrate a record of fiscal responsibility and the ability to provide sufficient
and effective oversight. Financial management systems must meet the requirements as
described 2 CFR 200 which include, but are not limited to, the following:

25 of 48

 Records that identify adequately the source and application of funds for federally-funded
activities.
 Effective control over, and accountability for, all funds, property, and other assets.
 Comparison of expenditures with budget amounts for each Federal award.
 Written procedures to implement payment requirements.
 Written procedures for determining cost allowability.
 Written procedures for financial reporting and monitoring.

14. Intergovernmental Review
The application is subject to Intergovernmental Review of Federal Programs, as governed by
Executive Order 12372, which established a system for state and local intergovernmental
review of proposed federal assistance applications. Applicants should inform their state single
point of contact (SPOC) as early as possible that they are applying prospectively for federal
assistance and request instructions on the state's process. The current SPOC list is available at:
http://www.whitehouse.gov/omb/grants_spoc/.
15. Pilot Program for Enhancement of Employee Whistleblower Protections
Pilot Program for Enhancement of Employee Whistleblower Protections: All applicants will be
subject to a term and condition that applies the terms of 48 Code of Federal Regulations
(CFR) section 3.908 to the award and requires that recipients inform their employees in writing
(in the predominant native language of the workforce) of employee whistleblower rights and
protections under 41 U.S.C. 4712.

16. Copyright Interests Provisions
This provision is intended to ensure that the public has access to the results and
accomplishments of public health activities funded by CDC. Pursuant to applicable grant
regulations and CDC’s Public Access Policy, Recipient agrees to submit into the National
Institutes of Health (NIH) Manuscript Submission (NIHMS) system an electronic version of the
final, peer-reviewed manuscript of any such work developed under this award upon acceptance
for publication, to be made publicly available no later than 12 months after the official date of
publication. Also at the time of submission, Recipient and/or the Recipient’s submitting author
must specify the date the final manuscript will be publicly accessible through PubMed Central
(PMC). Recipient and/or Recipient’s submitting author must also post the manuscript through
PMC within twelve (12) months of the publisher's official date of final publication; however the
author is strongly encouraged to make the subject manuscript available as soon as possible. The
recipient must obtain prior approval from the CDC for any exception to this provision.
The author's final, peer-reviewed manuscript is defined as the final version accepted for journal
publication, and includes all modifications from the publishing peer review process, and all
graphics and supplemental material associated with the article. Recipient and its submitting
authors working under this award are responsible for ensuring that any publishing or copyright
agreements concerning submitted articles reserve adequate right to fully comply with this
26 of 48

provision and the license reserved by CDC. The manuscript will be hosted in both PMC and the
CDC Stacks institutional repository system. In progress reports for this award, recipient must
identify publications subject to the CDC Public Access Policy by using the applicable NIHMS
identification number for up to three (3) months after the publication date and the PubMed
Central identification number (PMCID) thereafter.
17. Funding Restrictions
Restrictions that must be considered while planning the programs and writing the budget are:
 Recipients may not use funds for research.
 Recipients may not use funds for clinical care except as allowed by law.
 Recipients may use funds only for reasonable program purposes, including personnel,
travel, supplies, and services.
 Generally, recipients may not use funds to purchase furniture or equipment. Any such
proposed spending must be clearly identified in the budget.
 Reimbursement of pre-award costs generally is not allowed, unless the CDC provides
written approval to the recipient.
 Other than for normal and recognized executive-legislative relationships, no funds may
be used for:
o publicity or propaganda purposes, for the preparation, distribution, or use of any
material designed to support or defeat the enactment of legislation before any
legislative body
o the salary or expenses of any grant or contract recipient, or agent acting for such
recipient, related to any activity designed to influence the enactment of
legislation, appropriations, regulation, administrative action, or Executive order
proposed or pending before any legislative body
 See Additional Requirement (AR) 12 for detailed guidance on this prohibition
and additional guidance on lobbying for CDC recipients.
 The direct and primary recipient in a cooperative agreement program must perform a
substantial role in carrying out project outcomes and not merely serve as a conduit for an
award to another party or provider who is ineligible.
 In accordance with the United States Protecting Life in Global Health Assistance policy,
all non-governmental organization (NGO) applicants acknowledge that foreign NGOs
that receive funds provided through this award, either as a prime recipient or
subrecipient, are strictly prohibited, regardless of the source of funds, from performing
abortions as a method of family planning or engaging in any activity that promotes
abortion as a method of family planning, or to provide financial support to any other
foreign non-governmental organization that conducts such activities. See Additional
Requirement (AR) 35 for applicability
(https://www.cdc.gov/grants/additionalrequirements/ar-35.html).

27 of 48

18. Data Management Plan
As identified in the Evaluation and Performance Measurement section, applications involving
data collection must include a Data Management Plan (DMP) as part of their evaluation and
performance measurement plan. The DMP is the applicant’s assurance of the quality of the
public health data through the data’s lifecycle and plans to deposit data in a repository to
preserve and to make the data accessible in a timely manner. See web link for additional
information:
https://www.cdc.gov/grants/additionalrequirements/ar-25.html
19. Other Submission Requirements
a. Electronic Submission: Applications must be submitted electronically at www.grants.gov.
The application package can be downloaded at www.grants.gov. Applicants can complete the
application package off-line and submit the application by uploading it at www.grants.gov. All
application attachments must be submitted using a PDF file format. Directions for creating PDF
files can be found at www.grants.gov. File formats other than PDF may not be readable by OGS
Technical Information Management Section (TIMS) staff.
Applications must be submitted electronically by using the forms and instructions posted for
this notice of funding opportunity at www.grants.gov. Applicants can complete the application
package using Workspace, which allows forms to be filled out online or offline. All application
attachments must be submitted using a PDF file format. Instructions and training for using
Workspace can be found at www.grants.gov under the "Workspace Overview" option.
If Internet access is not available or if the forms cannot be accessed online, applicants may
contact the OGS TIMS staff at 770- 488-2700 or by e-mail at ogstims@cdc.gov, Monday
through Friday, 7:30 a.m.–4:30 p.m., except federal holidays. Electronic applications will be
considered successful if they are available to OGS TIMS staff for processing
from www.grants.gov on the deadline date.
b. Tracking Number: Applications submitted through www.grants.gov are time/date stamped
electronically and assigned a tracking number. The applicant’s Authorized Organization
Representative (AOR) will be sent an e-mail notice of receipt when www.grants.gov receives
the application. The tracking number documents that the application has been submitted and
initiates the required electronic validation process before the application is made available to
CDC.
c. Validation Process: Application submission is not concluded until the validation process is
completed successfully. After the application package is submitted, the applicant will receive a
“submission receipt” e-mail generated by www.grants.gov. A second e-mail message to
applicants will then be generated by www.grants.gov that will either validate or reject the
submitted application package. This validation process may take as long as two business days.
Applicants are strongly encouraged to check the status of their application to ensure that
submission of their package has been completed and no submission errors have occurred.
Applicants also are strongly encouraged to allocate ample time for filing to guarantee that their
application can be submitted and validated by the deadline published in the NOFO. Non-

28 of 48

validated applications will not be accepted after the published application deadline date.
If you do not receive a “validation” e-mail within two business days of application submission,
please contact www.grants.gov. For instructions on how to track your application, refer to the email message generated at the time of application submission or the Grants.gov Online User
Guide.
https:// www.grants.gov/help/html/help/index.htm? callingApp=custom#t=
Get_Started%2FGet_Started. htm
d. Technical Difficulties: If technical difficulties are encountered at www.grants.gov,
applicants should contact Customer Service at www.grants.gov. The www.grants.gov Contact
Center is available 24 hours a day, 7 days a week, except federal holidays. The Contact Center
is available by phone at 1-800-518-4726 or by e-mail at support@grants.gov. Application
submissions sent by e-mail or fax, or on CDs or thumb drives will not be accepted. Please note
that www.grants.gov is managed by HHS.
e. Paper Submission: If technical difficulties are encountered at www.grants.gov, applicants
should call the www.grants.gov Contact Center at 1-800-518-4726 or e-mail them
at support@grants.gov for assistance. After consulting with the Contact Center, if the technical
difficulties remain unresolved and electronic submission is not possible, applicants may e-mail
CDC GMO/GMS, before the deadline, and request permission to submit a paper application.
Such requests are handled on a case-by-case basis.
An applicant’s request for permission to submit a paper application must:
1. Include the www.grants.gov case number assigned to the inquiry
2. Describe the difficulties that prevent electronic submission and the efforts taken with
the www.grants.gov Contact Center to submit electronically; and
3. Be received via e-mail to the GMS/GMO listed below at least three calendar days before
the application deadline. Paper applications submitted without prior approval will not be
considered.
If a paper application is authorized, OGS will advise the applicant of specific
instructions for submitting the application (e.g., original and two hard copies of the
application by U.S. mail or express delivery service).

E. Review and Selection Process
1. Review and Selection Process: Applications will be reviewed in three phases
a. Phase 1 Review
All applications will be initially reviewed for eligibility and completeness by CDC Office of
Grants Services. Complete applications will be reviewed for responsiveness by the Grants
Management Officials and Program Officials. Non-responsive applications will not advance to
Phase II review. Applicants will be notified that their applications did not meet eligibility and/or
published submission requirements.

29 of 48

b. Phase II Review
A review panel will evaluate complete, eligible applications in accordance with the criteria
below.
i. Approach
ii. Evaluation and Performance Measurement
iii. Applicant’s Organizational Capacity to Implement the Approach
Not more than thirty days after the Phase II review is completed, applicants will be notified
electronically if their application does not meet eligibility or published submission
requirements.
i. Approach
Evaluate the extent to which the applicant:

Maximum Points:50

1. Describes conditions that exist and contribute to lead poisoning, such as homes built
prior to 1978, low-income or subsidized housing with known or suspected lead hazards; and
percent of children with elevated BLLs. (5 points)
2. Justifies the need for this program within its geographic area and adequately describes subpopulations at greatest risk for lead poisoning. (4 points)
3. Demonstrates strategies to implement a plan for blood lead testing of children less than 6
years (72 months) of age, including an emphasis on universal testing of Medicaid-enrolled
children. (5 Points)
4. Demonstrates strategies to implement or improve blood lead surveillance.
Does the applicant describe the establishment of or the operation of the Healthy
Homes and Lead Poisoning Surveillance System or an equivalent surveillance system
that will collect, compile, and track blood lead data and lead hazards data? (10 points)
Does the applicant describe how they will conduct analyses of surveillance data? (8
Points)
Does the applicant describe a plan to ensure that data is submitted to CDC quarterly?
(2 Points)
Does the applicant describe a surveillance reporting system and dissemination plan?
(5 Points)
(e.g., Does the plan include how data will be: Collected? Reported? Shared with
partners? Disseminated to the public?)
5. Demonstrates the capacity to strengthen population-based interventions.
Does the applicant describe building or maintaining collaborative relationships with
community, local, and state partners and stakeholders to address priority childhood
lead poisoning prevention challenges and opportunities? (1 Point)
Does the applicant describe a plan to educate public, partners, and stakeholders about
lead-related issues? (1 Point)
Does the applicant describe a plan to develop and conduct outreach and education to

30 of 48

lead workforce, partners, and other stakeholders? (1 Point)
Does the applicant have data-sharing agreements in place with housing, code
enforcement, and other health agencies? (1 Point)
Does the applicant describe their ability to use surveillance data to target appropriate
population-based, primary prevention interventions in high risk areas by collaborating
with housing rehabilitation, housing and health code enforcement, health care systems
and early childhood and other educational agencies? (1 Point)
6. Describes a process to identify lead-exposed children and link them to services.
Does the applicant describe a plan to identify lead exposed children and develop
guidance for follow-up care? (2 Points)
Does the applicant describe a plan to track timeliness and efficacy of follow-up
activities? (2 Points)
Does the applicant describe a plan to provide education and outreach to parents and
providers of lead-exposed children? (2 Points)
ii. Evaluation and Performance Measurement
Evaluate the extent to which the applicant:

Maximum Points:25

Presents performance measures and demonstrates how they will implement them. (15 Points)
Includes a work plan that is aligned with the strategies/activities and outcomes of this NOFO.
(10 Points)
iii. Applicant's Organizational Capacity to Implement the
Approach
Evaluate the extent to which the applicant:

Maximum Points:25

Provides a staffing plan of current and proposed personnel, including qualifications and
specific expertise as it relates to the requirements set forth in this announcement (e.g., CVs for
staff).
If applicable, provides a plan for identifying and hiring qualified applicants on a timely basis.
(10 Points)
Demonstrates that adequate staffing are available to perform activities outlined section in the
NOFO. (10 Points)
Demonstrates that surveillance data collection efforts maximally leverage existing tools and
systems and adhere to national data and technology standards to support interoperability of
system-to-system data exchange. (5 points)
Budget
Reviewed, but not scored:
The budget will be evaluated for the extent to which it is reasonable, clearly justified, and
consistent with the intended use of the cooperative agreement funds. The applicant shall
describe and indicate the availability of facilities and equipment necessary to carry out this
project.

31 of 48

If the applicant requests indirect costs in the budget, a copy of the indirect cost rate agreement
is required. If the indirect cost rate is a provisional rate, the agreement should be less than 12
months of age. The indirect cost rate agreement should be uploaded as a PDF file with “Other
Attachment Forms” when submitting via Grants.gov.
The applicant can obtain guidance for completing a detailed justified budget on the CDC
website at http://www.cdc.gov/funding.

c. Phase III Review

Not Applicable
Review of risk posed by applicants.
Prior to making a Federal award, CDC is required by 31 U.S.C. 3321 and 41 U.S.C. 2313 to
review information available through any OMB-designated repositories of government-wide
eligibility qualification or financial integrity information as appropriate. See also suspension
and debarment requirements at 2 CFR parts 180 and 376.
In accordance 41 U.S.C. 2313, CDC is required to review the non-public segment of the OMBdesignated integrity and performance system accessible through SAM (currently the
Federal Recipient Performance and Integrity Information System (FAPIIS)) prior to making a
Federal award where the Federal share is expected to exceed the simplified acquisition
threshold, defined in 41 U.S.C. 134, over the period of performance. At a minimum, the
information in the system for a prior Federal award recipient must demonstrate a satisfactory
record of executing programs or activities under Federal grants, cooperative agreements, or
procurement awards; and integrity and business ethics. CDC may make a Federal award to a
recipient who does not fully meet these standards, if it is determined that the information is not
relevant to the current Federal award under consideration or there are specific conditions that
can appropriately mitigate the effects of the non-Federal entity's risk in accordance with 45 CFR
§75.207.
CDC’s framework for evaluating the risks posed by an applicant may incorporate results of the
evaluation of the applicant's eligibility or the quality of its application. If it is determined that a
Federal award will be made, special conditions that correspond to the degree of risk assessed
may be applied to the Federal award. The evaluation criteria is described in this Notice of
Funding Opportunity.
In evaluating risks posed by applicants, CDC will use a risk-based approach and may consider
any items such as the following:
(1) Financial stability;
(2) Quality of management systems and ability to meet the management standards prescribed in
this part;
(3) History of performance. The applicant's record in managing Federal awards, if it is a prior
recipient of Federal awards, including timeliness of compliance with applicable reporting
requirements, conformance to the terms and conditions of previous Federal awards, and if
applicable, the extent to which any previously awarded amounts will be expended prior to

32 of 48

future awards;
(4) Reports and findings from audits performed under subpart F 45 CFR 75 or the reports and
findings of any other available audits; and
(5) The applicant's ability to effectively implement statutory, regulatory, or other requirements
imposed on non-Federal entities.
CDC must comply with the guidelines on government-wide suspension and debarment in 2
CFR part 180, and require non-Federal entities to comply with these provisions. These
provisions restrict Federal awards, subawards and contracts with certain parties that are
debarred, suspended or otherwise excluded from or ineligible for participation in Federal
programs or activities.

2. Announcement and Anticipated Award Dates
Awards will be announced on or about: 09/01/2018; Anticipated Award Start Date: 9/30/2018
F. Award Administration Information
1. Award Notices
Recipients will receive an electronic copy of the Notice of Award (NOA) from CDC OGS. The
NOA shall be the only binding, authorizing document between the recipient and CDC. The
NOA will be signed by an authorized GMO and emailed to the Recipient Business Officer listed
in application and the Program Director.
Any applicant awarded funds in response to this Notice of Funding Opportunity will be subject
to the DUNS, SAM Registration, and Federal Funding Accountability And Transparency Act
Of 2006 (FFATA) requirements.
Unsuccessful applicants will receive notification of these results by e-mail with delivery receipt
or by U.S. mail.
2. Administrative and National Policy Requirements
Recipients must comply with the administrative and public policy requirements outlined in 45
CFR Part 75 and the HHS Grants Policy Statement, as appropriate.
Brief descriptions of relevant provisions are available
at http://www.cdc.gov/grants/additionalrequirements/index.html#ui-id-17.
The HHS Grants Policy Statement is available
at http://www.hhs.gov/sites/default/files/grants/grants/policies-regulations/hhsgps107.pdf.

The full text of the Uniform Administrative Requirements, Cost Principles, and Audit
Requirements for HHS Awards, 45 CFR 75, can be found at: https://www.ecfr.gov/cgi-bin/textidx?node=pt45.1.75
3. Reporting
Reporting provides continuous program monitoring and identifies successes and challenges
33 of 48

that recipients encounter throughout the project period. Also, reporting is a requirement
for recipients who want to apply for yearly continuation of funding. Reporting helps CDC and
recipients because it:
 Helps target support to recipients;
 Provides CDC with periodic data to monitor recipient progress toward meeting
the Notice of Funding Opportunity outcomes and overall performance;
 Allows CDC to track performance measures and evaluation findings for continuous
quality and program improvement throughout the period of performance and to
determine applicability of evidence-based approaches to different populations, settings,
and contexts; and
 Enables CDC to assess the overall effectiveness and influence of the NOFO.
The table below summarizes required and optional reports. All required reports must be sent
electronically to GMS listed in the “Agency Contacts” section of the NOFO copying the CDC
Project Officer.

Report

When?

Required?

Evaluation and Performance
Measurement Plan including Data
Management Plan (DMP)

6 months into award.

Yes

Surveillance Data Reports

Quarterly reports due by
end of following quarter
for each budget period:
Yes
March 31, June 30,
September 30, December
31.
No later than 120 days
Yes
before end of budget
period. Serves as yearly
continuation application.

Annual Performance Report
(APR)

Federal Financial Reporting Forms

Final Performance and Financial Report

90 days after end of
calendar quarter in which
budget period ends.

Yes

90 days after end of Period Yes
of Performance.

34 of 48

Payment Management System
(PMS) Reporting

Quarterly reports due
Yes
January 31, 2019; April
30, 2019; July 31, 2019;
October 31, 2019; January
31, 2020; April 30, 2020;
July 31, 2020.

a. Recipient Evaluation and Performance Measurement Plan (required)
With support from CDC, recipients must elaborate on their initial applicant evaluation and
performance measurement plan. This plan must be no more than 20 pages; recipients must
submit the plan 6 months into the award. HHS/CDC will review and approve the recipient’s
monitoring and evaluation plan to ensure that it is appropriate for the activities to be undertaken
as part of the agreement, for compliance with the monitoring and evaluation guidance
established by HHS/CDC, or other guidance otherwise applicable to this Agreement.
Recipient Evaluation and Performance Measurement Plan (required): This plan should provide
additional detail on the following:
Performance Measurement
• Performance measures and targets
• The frequency that performance data are to be collected.
• How performance data will be reported.
• How quality of performance data will be assured.
• How performance measurement will yield findings to demonstrate progress towards
achieving NOFO goals (e.g., reaching target populations or achieving expected outcomes).
• Dissemination channels and audiences.
• Other information requested as determined by the CDC program.
Evaluation
• The types of evaluations to be conducted (e.g. process or outcome evaluations).
• The frequency that evaluations will be conducted.
• How evaluation reports will be published on a publically available website.
• How evaluation findings will be used to ensure continuous quality and program improvement.
• How evaluation will yield findings to demonstrate the value of the NOFO (e.g., effect on
improving public health outcomes, effectiveness of NOFO, cost-effectiveness or cost-benefit).
• Dissemination channels and audiences.
HHS/CDC or its designee will also undertake monitoring and evaluation of the defined
activities within the agreement. The recipient must ensure reasonable access by HHS/CDC or
its designee to all necessary sites, documentation, individuals and information to monitor,
evaluate and verify the appropriate implementation the activities and use of HHS/CDC funding
under this Agreement.
b. Annual Performance Report (APR) (required)

35 of 48

The recipient must submit the APR via www.Grantsolutions.gov no later than120 days prior to
the end of the budget period. This report must not exceed 45 pages excluding administrative
reporting. Attachments are not allowed, but web links are allowed.
This report must include the following:
 Performance Measures: Recipients must report on performance measures for each
budget period and update measures, if needed.
 Evaluation Results: Recipients must report evaluation results for the work completed to
date (including findings from process or outcome evaluations).
 Work Plan: Recipients must update work plan each budget period to reflect any
changes in period of performance outcomes, activities, timeline, etc.
 Successes
o Recipients must report progress on completing activities and progress towards
achieving the period of performance outcomes described in the logic model and
work plan.
o Recipients must describe any additional successes (e.g. identified through
evaluation results or lessons learned) achieved in the past year.
o Recipients must describe success stories.
 Challenges
o Recipients must describe any challenges that hindered or might hinder their
ability to complete the work plan activities and achieve the period of
performance outcomes.
o Recipients must describe any additional challenges (e.g., identified through
evaluation results or lessons learned) encountered in the past year.
 CDC Program Support to Recipients
o Recipients must describe how CDC could help them overcome challenges to
complete activities in the work plan and achieving period of performance
outcomes.
 Administrative Reporting (No page limit)
o SF-424A Budget Information-Non-Construction Programs.
o Budget Narrative – Must use the format outlined in "Content and Form of
Application Submission, Budget Narrative" section.
o Indirect Cost Rate Agreement.
In addition, the Recipients should complete the following requirements in their Annual
Performance Report:
Requirement 1 - Complete annual web-based Awardee Lead Profile Assessment. CDC will
provide the link to the assessment upon request. The purpose of the assessment is to identify: 1)
jurisdictional legal frameworks governing CDC-funded childhood lead poisoning prevention
programs in the United States and 2) strategies for implementing childhood lead poisoning
prevention activities in the United States.
Requirement 2 - Complete the Performance Measures reporting document to state progress
toward short-term outcomes of this cooperative agreement. Baseline and Target figures must be
documented during the first reporting in 2019. CDC will provide this document upon request.

36 of 48

Requirement 3 - In the narrative, describe progress to date, and address the following elements
related to this cooperative agreement’s short-term outcomes:
Increased numbers of children less than 6 years (less than 72 months) of age tested for blood
lead.
 Describe the criteria used to identify high-risk geographic areas.
 List the targeted high-risk geographic areas that have been identified.
 To the extent possible, provide the number of children less than 6 years (less than 72
months) of age that live in high-risk geographic areas
 Describe the criteria used to identify children at-risk for lead poisoning and targeted for
lead poisoning prevention interventions.
 List the at-risk populations that have been identified using recent surveillance data
 Provide the number of children less than 6 years (less than 72 months) of age considered
at-risk.
Improved availability and use of data that leads to improved identification of geographic areas
and populations at high risk for lead
 Describe the current surveillance system and its capacity to collect electronic laboratory
results, store demographic and housing variables (in addition to blood lead test results),
prepare reports for submission to CDC, and track referrals for follow-up services.
 Describe current resources used to analyze and report data.
 Describe data from other organizations and agencies used to analyze and report data (ex.
census, tax assessor).
 Describe how data is reported to partners and other stakeholders.
Increased ability to target population-based interventions to high-risk geographic areas and
populations.
 List partner organizations and institutions engaged in brainstorming, strategizing,
planning, implementing, or evaluating interventions for lead poisoning prevention for
targeted at-risk populations.
 Describe each partner’s level of engagement
 Describe challenges and opportunities associated with leveraging partnerships to target
interventions.
Increased identification of lead-exposed children who receive appropriate linkages to
recommended follow-up. List common referred follow-up services for lead-exposed children
and describe the circumstances that initiate each type of referral. Follow-up services can include
additional blood lead tests, visual inspections of potential exposure sites, home assessments,
risk assessments, home remediation and repair, social service outreach, community resource
connections, nutrition services, medical homes, developmental tracking and special education
services, and the like.
 Describe the current process (or plans for a future process) to ensure tracking of referrals

37 of 48

made and received for lead-exposed children.
Requirement 4 – Submit a success story based on one of the activities in your annual report. A
concise success story has one clearly defined issue or problem, describes an intervention taken
to address that issue, and tells the impact or outcome of that intervention. Examples are
available at the bottom of the internet page at https://www.cdc.gov/nceh/lead/programs/default
.htm, Use the guidance below to guide the creation of their success story.
Success Story Criteria
Title
Does the title:
1. Capture the attention of the reader?
2. Avoid acronyms?
3. Contain a verb?
Issue
Does the issue statement:
1. Have a strong lead sentence?
2. Provide local, regional, or state information about the issue?
3. Tie the burden (health, training, or threat) to a cost burden?
4. Specify the affected population?
5. Provide an emotional hook?
6. Present a clear, concise statement about a single issue?
Intervention
Does the intervention statement:
1. Have a strong lead sentence that transitions the issue section to the intervention section?
2. Identify who conducted the intervention?
3. Identify where and when the intervention occurred?
4. Specify the steps of the intervention?
Impact
Does the impact statement:
1. Give specific outcomes? (e.g., money saved, change in health outcomes, number of people
affected)
2. Avoid broad, sweeping statements?
3. Provide conclusions that wrap up the story in a convincing manner?

38 of 48

General Formatting
Does the success story:
1. Avoid wordiness, passive language, and grammatical and spelling errors?
2. Use terms that are understood by a non-public health audience? (avoids jargon)
3. Use one page if possible?
4. Use bullets where possible?
5. Include contact information?
The recipients must submit the Annual Performance Report via www.Grantsolutions.gov no
later than 120 days prior to the end of the budget period.
c. Performance Measure Reporting (optional)
CDC programs may require more frequent reporting of performance measures than annually in
the APR. If this is the case, CDC programs must specify reporting frequency, data fields, and
format for recipients at the beginning of the award period.
Surveillance Data Reports: Quarterly blood lead surveillance data required variable extracts are
due by end of following quarter for each budget period: March 31, June 30, September 30,
December 31.

d. Federal Financial Reporting (FFR) (required)
The annual FFR form (SF-425) is required and must be submitted 90 days after the end of the
budget period. The report must include only those funds authorized and disbursed during the
timeframe covered by the report. The final FFR must indicate the exact balance of unobligated
funds, and may not reflect any unliquidated obligations. There must be no discrepancies
between the final FFR expenditure data and the Payment Management System’s (PMS) cash
transaction data. Failure to submit the required information by the due date may adversely affect
the future funding of the project. If the information cannot be provided by the due
date, recipients are required to submit a letter of explanation to OGS and include the date by
which the Grants Officer will receive information.
e. Final Performance and Financial Report (required)
This report is due 90 days after the end of the period of performance. CDC programs must
indicate that this report should not exceed 40 pages. This report covers the entire period of
performance and can include information previously reported in APRs. At a minimum, this
report must include the following:
 Performance Measures – Recipients must report final performance data for all process
and outcome performance measures.
 Evaluation Results – Recipients must report final evaluation results for the period of
performance for any evaluations conducted.

39 of 48

 Impact/Results/Success Stories – Recipients must use their performance measure results
and their evaluation findings to describe the effects or results of the work completed
over the project period, and can include some success stories.
 A final Data Management Plan that includes the location of the data collected during the
funded period, for example, repository name and link data set(s)
 Additional forms as described in the Notice of Award (e.g., Equipment Inventory
Report, Final Invention Statement).
The annual FFR form (SF-425) is required and must be submitted 90 days after the end of the
period of performance. The report must include only those funds authorized and disbursed
during the time frame covered by the report. The final FFR must indicate the exact balance of
unobligated funds, and may not reflect any unliquidated obligations. There must be no
discrepancies between the final FFR expenditure data and the Payment Management System’s
(PMS) cash transaction data. Failure to submit the required information by the due date may
adversely affect the future funding of the project. If the information cannot be provided by the
due date, recipients are required to submit a letter of explanation to OGS and include the date by
which the Grants Officer will receive information. The FFR must be completed by Recipients
in www.grantsolutions.gov.

4. Federal Funding Accountability and Transparency Act of 2006 (FFATA)
Federal Funding Accountability and Transparency Act of 2006 (FFATA), P.L. 109–282, as
amended by section 6202 of P.L. 110–252 requires full disclosure of all entities and
organizations receiving Federal funds including awards, contracts, loans, other assistance, and
payments through a single publicly accessible Web site, http://www.USASpending.gov.
Compliance with this law is primarily the responsibility of the Federal agency. However, two
elements of the law require information to be collected and reported by applicants: 1)
information on executive compensation when not already reported through the SAM, and 2)
similar information on all sub-awards/subcontracts/consortiums over $25,000.
For the full text of the requirements under the FFATA and HHS guidelines, go to:
 https://www.gpo.gov/fdsys/pkg/PLAW-109publ282/pdf/PLAW-109publ282.pdf,
 https://www. fsrs.gov/documents /ffata_legislation_ 110_252.pdf
 http://www.hhs.gov/grants/grants/grants-policies-regulations/index.html#FFATA.
5. Reporting of Foreign Taxes (International/Foreign projects only)
A. Valued Added Tax (VAT) and Customs Duties – Customs and import duties, consular fees,
customs surtax, valued added taxes, and other related charges are hereby authorized as an
allowable cost for costs incurred for non-host governmental entities operating where no
applicable tax exemption exists. This waiver does not apply to countries where a bilateral
agreement (or similar legal document) is already in place providing applicable tax exemptions
and it is not applicable to Ministries of Health. Successful applicants will receive information
on VAT requirements via their Notice of Award.

40 of 48

B. The U.S. Department of State requires that agencies collect and report information on the
amount of taxes assessed, reimbursed and not reimbursed by a foreign government against
commodities financed with funds appropriated by the U.S. Department of State, Foreign
Operations and Related Programs Appropriations Act (SFOAA) (“United States foreign
assistance funds”). Outlined below are the specifics of this requirement:
1) Annual Report: The recipient must submit a report on or before November 16 for each
foreign country on the amount of foreign taxes charged, as of September 30 of the same year,
by a foreign government on commodity purchase transactions valued at 500 USD or more
financed with United States foreign assistance funds under this grant during the prior United
States fiscal year (October 1 – September 30), and the amount reimbursed and unreimbursed by
the foreign government. [Reports are required even if the recipient did not pay any taxes during
the reporting period.]
2) Quarterly Report: The recipient must quarterly submit a report on the amount of foreign taxes
charged by a foreign government on commodity purchase transactions valued at 500 USD or
more financed with United States foreign assistance funds under this grant. This report shall be
submitted no later than two weeks following the end of each quarter: April 15, July 15, October
15 and January 15.
3) Terms: For purposes of this clause:
“Commodity” means any material, article, supplies, goods, or equipment;
“Foreign government” includes any foreign government entity;
“Foreign taxes” means value-added taxes and custom duties assessed by a foreign government
on a commodity. It does not include foreign sales taxes.
4) Where: Submit the reports to the Director and Deputy Director of the CDC office in the
country(ies) in which you are carrying out the activities associated with this cooperative
agreement. In countries where there is no CDC office, send reports to VATreporting@cdc.gov.
5) Contents of Reports: The reports must contain:
a. recipient name;
b. contact name with phone, fax, and e-mail;
c. agreement number(s) if reporting by agreement(s);
d. reporting period;
e. amount of foreign taxes assessed by each foreign government;
f. amount of any foreign taxes reimbursed by each foreign government;
g. amount of foreign taxes unreimbursed by each foreign government.
6) Subagreements. The recipient must include this reporting requirement in all applicable
subgrants and other subagreements.
G. Agency Contacts
CDC encourages inquiries concerning this notice of funding opportunity.

41 of 48

Program Office Contact
For programmatic technical assistance, contact:
CDR Monica Leonard, Project Officer
Department of Health and Human Services
Centers for Disease Control and Prevention
Program Services Team Lead
Lead Poisoning Prevention Section
Lead Poisoning Prevention and Environmental Health Tracking Branch
Division of Environmental Health Science and Practice
National Center for Environmental Health

Telephone: (404) 498-1826
Email: zgf7@cdc.gov
Grants Staff Contact
For financial, awards management, or budget assistance, contact:
Victoria McBee, Grants Management Specialist
Department of Health and Human Services
Office of Grants Services
Grants Management Specialist
Time Solutions, LLC Contractor
Office of Grants Services
Office of Financial Resources
Office of the Chief Operating Officer
Telephone: (770) 488-2825
Email: yig9@cdc.gov
For assistance with submission difficulties related to www.grants.gov, contact the Contact
Center by phone at 1-800-518-4726.
Hours of Operation: 24 hours a day, 7 days a week, except on federal holidays.
For all other submission questions, contact:
Technical Information Management Section

42 of 48

Department of Health and Human Services
CDC Office of Financial Resources
Office of Grants Services
2920 Brandywine Road, MS E-14
Atlanta, GA 30341
Telephone: 770-488-2700
CDC Telecommunications for persons with hearing loss is available at: TTY 1-888-232-6348
H. Other Information
Following is a list of acceptable attachments applicants can upload as PDF files as part of their
application at www.grants.gov. Applicants may not attach documents other than those listed; if
other documents are attached, applications will not be reviewed.







Project Abstract
Project Narrative
Budget Narrative
CDC Assurances and Certifications
Report on Programmatic, Budgetary and Commitment Overlap
Table of Contents for Entire Submission

For international NOFOs:
 SF424
 SF424A
 Funding Preference Deliverables
Optional attachments, as determined by CDC programs:










Resumes / CVs
Position descriptions
Letters of Support
Organization Charts
Non-profit organization IRS status forms, if applicable
Indirect Cost Rate, if applicable
Memorandum of Agreement (MOA)
Memorandum of Understanding (MOU)
Bona Fide Agent status documentation, if applicable

43 of 48

I. Glossary
Activities: The actual events or actions that take place as a part of the program.
Administrative and National Policy Requirements, Additional Requirements
(ARs): Administrative requirements found in 45 CFR Part 75 and other requirements mandated
by statute or CDC policy. All ARs are listed in the Template for CDC programs. CDC programs
must indicate which ARs are relevant to the NOFO; recipients must comply with the ARs listed
in the NOFO. To view brief descriptions of relevant provisions, see http:// www.cdc.gov/
grants/ additional requirements/ index.html. Note that 2 CFR 200 supersedes the administrative
requirements (A-110 & A-102), cost principles (A-21, A-87 & A-122) and audit requirements
(A-50, A-89 & A-133).
Approved but Unfunded: Approved but unfunded refers to applications recommended for
approval during the objective review process; however, they were not recommended for funding
by the program office and/or the grants management office.
Assitance Listings (CFDA): A government-wide compendium published by the General
Services Administration (available on-line in searchable format as well as in printable format as
a .pdf file) that describes domestic assistance programs administered by the Federal
Government.
Assistance Listings (CFDA) Number: A unique number assigned to each program and NOFO
throughout its lifecycle that enables data and funding tracking and transparency
Award: Financial assistance that provides support or stimulation to accomplish a public
purpose. Awards include grants and other agreements (e.g., cooperative agreements) in the form
of money, or property in lieu of money, by the federal government to an eligible applicant.
Budget Period or Budget Year: The duration of each individual funding period within the
project period. Traditionally, budget periods are 12 months or 1 year.
Carryover: Unobligated federal funds remaining at the end of any budget period that, with the
approval of the GMO or under an automatic authority, may be carried over to another budget
period to cover allowable costs of that budget period either as an offset or additional
authorization. Obligated but liquidated funds are not considered carryover.
CDC Assurances and Certifications: Standard government-wide grant application forms.
Competing Continuation Award: A financial assistance mechanism that adds funds to a grant
and adds one or more budget periods to the previously established period of performance (i.e.,
extends the “life” of the award).
Continuous Quality Improvement: A system that seeks to improve the provision of services
with an emphasis on future results.
Contracts: An award instrument used to acquire (by purchase, lease, or barter) property or
services for the direct benefit or use of the Federal Government.
Cooperative Agreement: A financial assistance award with the same kind of interagency
relationship as a grant except that it provides for substantial involvement by the federal agency
funding the award. Substantial involvement means that the recipient can expect federal
programmatic collaboration or participation in carrying out the effort under the award.
Cost Sharing or Matching: Refers to program costs not borne by the Federal Government but
by the recipients. It may include the value of allowable third-party, in-kind contributions, as
well as expenditures by the recipient.

44 of 48

Direct Assistance: A financial assistance mechanism, which must be specifically authorized by
statute, whereby goods or services are provided to recipients in lieu of cash. DA generally
involves the assignment of federal personnel or the provision of equipment or supplies, such as
vaccines. DA is primarily used to support payroll and travel expenses of CDC employees
assigned to state, tribal, local, and territorial (STLT) health agencies that are recipients of grants
and cooperative agreements. Most legislative authorities that provide financial assistance to
STLT health agencies allow for the use of DA. http:// www.cdc.gov /grants
/additionalrequirements /index.html.
DUNS: The Dun and Bradstreet (D&B) Data Universal Numbering System (DUNS) number is
a nine-digit number assigned by Dun and Bradstreet Information Services. When applying for
Federal awards or cooperative agreements, all applicant organizations must obtain a DUNS
number as the Universal Identifier. DUNS number assignment is free. If requested by telephone,
a DUNS number will be provided immediately at no charge. If requested via the Internet,
obtaining a DUNS number may take one to two days at no charge. If an organization does not
know its DUNS number or needs to register for one, visit Dun & Bradstreet at
http://fedgov.dnb.com/ webform/displayHomePage.do.
Evaluation (program evaluation): The systematic collection of information about the
activities, characteristics, and outcomes of programs (which may include interventions, policies,
and specific projects) to make judgments about that program, improve program effectiveness,
and/or inform decisions about future program development.
Evaluation Plan: A written document describing the overall approach that will be used to guide
an evaluation, including why the evaluation is being conducted, how the findings will likely be
used, and the design and data collection sources and methods. The plan specifies what will be
done, how it will be done, who will do it, and when it will be done. The NOFO evaluation plan
is used to describe how the recipient and/or CDC will determine whether activities are
implemented appropriately and outcomes are achieved.
Federal Funding Accountability and Transparency Act of 2006 (FFATA): Requires that
information about federal awards, including awards, contracts, loans, and other assistance and
payments, be available to the public on a single website at www.USAspending.gov.
Fiscal Year: The year for which budget dollars are allocated annually. The federal fiscal year
starts October 1 and ends September 30.
Grant: A legal instrument used by the federal government to transfer anything of value to a
recipient for public support or stimulation authorized by statute. Financial assistance may be
money or property. The definition does not include a federal procurement subject to the Federal
Acquisition Regulation; technical assistance (which provides services instead of money); or
assistance in the form of revenue sharing, loans, loan guarantees, interest subsidies, insurance,
or direct payments of any kind to a person or persons. The main difference between a grant and
a cooperative agreement is that in a grant there is no anticipated substantial programmatic
involvement by the federal government under the award.
Grants.gov: A "storefront" web portal for electronic data collection (forms and reports) for
federal grant-making agencies at www.grants.gov.
Grants Management Officer (GMO): The individual designated to serve as the HHS official
responsible for the business management aspects of a particular grant(s) or cooperative
agreement(s). The GMO serves as the counterpart to the business officer of the recipient
organization. In this capacity, the GMO is responsible for all business management matters
associated with the review, negotiation, award, and administration of grants and interprets
45 of 48

grants administration policies and provisions. The GMO works closely with the program or
project officer who is responsible for the scientific, technical, and programmatic aspects of the
grant.
Grants Management Specialist (GMS): A federal staff member who oversees the business
and other non-programmatic aspects of one or more grants and/or cooperative agreements.
These activities include, but are not limited to, evaluating grant applications for administrative
content and compliance with regulations and guidelines, negotiating grants, providing
consultation and technical assistance to recipients, post-award administration and closing out
grants.
Health Disparities: Differences in health outcomes and their determinants among segments of
the population as defined by social, demographic, environmental, or geographic category.
Health Equity: Striving for the highest possible standard of health for all people and giving
special attention to the needs of those at greatest risk of poor health, based on social conditions.
Health Inequities: Systematic, unfair, and avoidable differences in health outcomes and their
determinants between segments of the population, such as by socioeconomic status (SES),
demographics, or geography.
Healthy People 2020: National health objectives aimed at improving the health of all
Americans by encouraging collaboration across sectors, guiding people toward making
informed health decisions, and measuring the effects of prevention activities.
Inclusion: Both the meaningful involvement of a community’s members in all stages of the
program process and the maximum involvement of the target population that the intervention
will benefit. Inclusion ensures that the views, perspectives, and needs of affected communities,
care providers, and key partners are considered.
Indirect Costs: Costs that are incurred for common or joint objectives and not readily and
specifically identifiable with a particular sponsored project, program, or activity; nevertheless,
these costs are necessary to the operations of the organization. For example, the costs of
operating and maintaining facilities, depreciation, and administrative salaries generally are
considered indirect costs.
Intergovernmental Review: Executive Order 12372 governs applications subject to
Intergovernmental Review of Federal Programs. This order sets up a system for state and local
governmental review of proposed federal assistance applications. Contact the state single point
of contact (SPOC) to alert the SPOC to prospective applications and to receive instructions on
the State’s process. Visit the following web address to get the current SPOC list:
https://www.whitehouse.gov/wp-content/uploads/2017/11/Intergovernmental_-Review_SPOC_01_2018_OFFM.pdf.
Letter of Intent (LOI): A preliminary, non-binding indication of an organization’s intent to
submit an application.
Lobbying: Direct lobbying includes any attempt to influence legislation, appropriations,
regulations, administrative actions, executive orders (legislation or other orders), or other
similar deliberations at any level of government through communication that directly expresses
a view on proposed or pending legislation or other orders, and which is directed to staff
members or other employees of a legislative body, government officials, or employees who
participate in formulating legislation or other orders. Grass roots lobbying includes efforts
directed at inducing or encouraging members of the public to contact their elected
representatives at the federal, state, or local levels to urge support of, or opposition to, proposed
or pending legislative proposals.
46 of 48

Logic Model: A visual representation showing the sequence of related events connecting the
activities of a program with the programs’ desired outcomes and results.
Maintenance of Effort: A requirement contained in authorizing legislation, or applicable
regulations that a recipient must agree to contribute and maintain a specified level of financial
effort from its own resources or other non-government sources to be eligible to receive federal
grant funds. This requirement is typically given in terms of meeting a previous base-year dollar
amount.
Memorandum of Understanding (MOU) or Memorandum of Agreement
(MOA): Document that describes a bilateral or multilateral agreement between parties
expressing a convergence of will between the parties, indicating an intended common line of
action. It is often used in cases where the parties either do not imply a legal commitment or
cannot create a legally enforceable agreement.
Nonprofit Organization: Any corporation, trust, association, cooperative, or other organization
that is operated primarily for scientific, educational, service, charitable, or similar purposes in
the public interest; is not organized for profit; and uses net proceeds to maintain, improve, or
expand the operations of the organization. Nonprofit organizations include institutions of higher
educations, hospitals, and tribal organizations (that is, Indian entities other than federally
recognized Indian tribal governments).
Notice of Award (NoA): The official document, signed (or the electronic equivalent of
signature) by a Grants Management Officer that: (1) notifies the recipient of the award of a
grant; (2) contains or references all the terms and conditions of the grant and Federal funding
limits and obligations; and (3) provides the documentary basis for recording the obligation of
Federal funds in the HHS accounting system.
Objective Review: A process that involves the thorough and consistent examination of
applications based on an unbiased evaluation of scientific or technical merit or other relevant
aspects of the proposal. The review is intended to provide advice to the persons responsible for
making award decisions.
Outcome: The results of program operations or activitIes; the effects triggered by the program.
For example, increased knowledge, changed attitudes or beliefs, reduced tobacco use, reduced
morbidity and mortality.
Performance Measurement: The ongoing monitoring and reporting of program
accomplishments, particularly progress toward pre-established goals, typically conducted by
program or agency management. Performance measurement may address the type or level of
program activities conducted (process), the direct products and services delivered by a program
(outputs), or the results of those products and services (outcomes). A “program” may be any
activity, project, function, or policy that has an identifiable purpose or set of objectives.
Period of performance –formerly known as the project period - : The time during which the
recipient may incur obligations to carry out the work authorized under the Federal award. The
start and end dates of the period of performance must be included in the Federal award.
Period of Performance Outcome: An outcome that will occur by the end of the NOFO’s
funding period
Plain Writing Act of 2010: The Plain Writing Act of 2010 requires that federal agencies use
clear communication that the public can understand and use. NOFOs must be written in clear,
consistent language so that any reader can understand expectations and intended outcomes of
the funded program. CDC programs should use NOFO plain writing tips when writing NOFOs.
Program Strategies: Strategies are groupings of related activities, usually expressed as general
47 of 48

headers (e.g., Partnerships, Assessment, Policy) or as brief statements (e.g., Form partnerships,
Conduct assessments, Formulate policies).
Program Official: Person responsible for developing the NOFO; can be either a project officer,
program manager, branch chief, division leader, policy official, center leader, or similar staff
member.
Public Health Accreditation Board (PHAB): A nonprofit organization that works to promote
and protect the health of the public by advancing the quality and performance of public health
departments in the U.S. through national public health department
accreditation http://www.phaboard.org.
Social Determinants of Health: Conditions in the environments in which people are born, live,
learn, work, play, worship, and age that affect a wide range of health, functioning, and qualityof-life outcomes and risks.
Statute: An act of the legislature; a particular law enacted and established by the will of the
legislative department of government, expressed with the requisite formalities. In foreign or
civil law any particular municipal law or usage, though resting for its authority on judicial
decisions, or the practice of nations.
Statutory Authority: Authority provided by legal statute that establishes a federal financial
assistance program or award.
System for Award Management (SAM): The primary vendor database for the U.S. federal
government. SAM validates applicant information and electronically shares secure and
encrypted data with federal agencies' finance offices to facilitate paperless payments through
Electronic Funds Transfer (EFT). SAM stores organizational information,
allowing www.grants.gov to verify identity and pre-fill organizational information on grant
applications.
Technical Assistance: Advice, assistance, or training pertaining to program development,
implementation, maintenance, or evaluation that is provided by the funding agency.
Work Plan: The summary of period of performance outcomes, strategies and activities,
personnel and/or partners who will complete the activities, and the timeline for completion. The
work plan will outline the details of all necessary activities that will be supported through the
approved budget.
NOFO-specific Glossary and Acronyms

48 of 48